| Ibrutinib for previously untreated and relapsed or refractory chronic lymphocytic leukaemia with TP53 aberrations: a phase 2, single-arm trial MZH Farooqui, J Valdez, S Martyr, G Aue, N Saba, CU Niemann, ... The lancet oncology 16 (2), 169-176, 2015 | 495 | 2015 |
| Clonal evolution leading to ibrutinib resistance in chronic lymphocytic leukemia IE Ahn, C Underbayev, A Albitar, SEM Herman, X Tian, I Maric, DC Arthur, ... Blood, The Journal of the American Society of Hematology 129 (11), 1469-1479, 2017 | 377 | 2017 |
| Time course of LDL cholesterol exposure and cardiovascular disease event risk MJ Domanski, X Tian, CO Wu, JP Reis, AK Dey, Y Gu, L Zhao, S Bae, ... Journal of the American College of Cardiology 76 (13), 1507-1516, 2020 | 327 | 2020 |
| Mortality in adults with sickle cell disease and pulmonary hypertension A Mehari, MT Gladwin, X Tian, RF Machado, GJ Kato Jama 307 (12), 1254-1256, 2012 | 247 | 2012 |
| Partial reconstitution of humoral immunity and fewer infections in patients with chronic lymphocytic leukemia treated with ibrutinib C Sun, X Tian, YS Lee, S Gunti, A Lipsky, SEM Herman, D Salem, ... Blood, The Journal of the American Society of Hematology 126 (19), 2213-2219, 2015 | 243 | 2015 |
| The BASILICA trial: prospective multicenter investigation of intentional leaflet laceration to prevent TAVR coronary obstruction JM Khan, AB Greenbaum, VC Babaliaros, T Rogers, MH Eng, G Paone, ... JACC: Cardiovascular Interventions 12 (13), 1240-1252, 2019 | 233 | 2019 |
| Depth and durability of response to ibrutinib in CLL: 5-year follow-up of a phase 2 study IE Ahn, MZH Farooqui, X Tian, J Valdez, C Sun, S Soto, J Lotter, S Housel, ... Blood, The Journal of the American Society of Hematology 131 (21), 2357-2366, 2018 | 223 | 2018 |
| Effect of dasatinib vs imatinib in the treatment of pediatric Philadelphia chromosome–positive acute lymphoblastic leukemia: A randomized clinical trial S Shen, X Chen, J Cai, J Yu, J Gao, S Hu, X Zhai, C Liang, X Ju, H Jiang, ... JAMA oncology 6 (3), 358-366, 2020 | 222 | 2020 |
| High prevalence of respiratory ciliary dysfunction in congenital heart disease patients with heterotaxy N Nakhleh, R Francis, RA Giese, X Tian, Y Li, MA Zariwala, H Yagi, ... Circulation 125 (18), 2232-2242, 2012 | 203 | 2012 |
| Incidence and risk factors of bleeding-related adverse events in patients with chronic lymphocytic leukemia treated with ibrutinib AH Lipsky, MZH Farooqui, X Tian, S Martyr, AM Cullinane, K Nghiem, ... Haematologica 100 (12), 1571, 2015 | 196 | 2015 |
| Anterior leaflet laceration to prevent ventricular outflow tract obstruction during transcatheter mitral valve replacement JM Khan, VC Babaliaros, AB Greenbaum, JR Foerst, S Yazdani, ... Journal of the American College of Cardiology 73 (20), 2521-2534, 2019 | 191 | 2019 |
| Atypical Pneumocystis jirovecii pneumonia in previously untreated patients with CLL on single-agent ibrutinib IE Ahn, T Jerussi, M Farooqui, X Tian, A Wiestner, J Gea-Banacloche Blood, The Journal of the American Society of Hematology 128 (15), 1940-1943, 2016 | 183 | 2016 |
| Pathogenic role of B-cell receptor signaling and canonical NF-κB activation in mantle cell lymphoma NS Saba, D Liu, SEM Herman, C Underbayev, X Tian, D Behrend, ... Blood, The Journal of the American Society of Hematology 128 (1), 82-92, 2016 | 175 | 2016 |
| Direct in vivo evidence for increased proliferation of CLL cells in lymph nodes compared to bone marrow and peripheral blood TM Herndon, SS Chen, NS Saba, J Valdez, C Emson, M Gatmaitan, ... Leukemia 31 (6), 1340-1347, 2017 | 143 | 2017 |
| Ibrutinib for Chronic Lymphocytic Leukemia with TP53 Alterations IE Ahn, X Tian, A Wiestner New England Journal of Medicine 383 (5), 498-500, 2020 | 132 | 2020 |
| Effect of Bruton tyrosine kinase inhibitor on efficacy of adjuvanted recombinant hepatitis B and zoster vaccines C Pleyer, MA Ali, JI Cohen, X Tian, S Soto, IE Ahn, EM Gaglione, ... Blood, The Journal of the American Society of Hematology 137 (2), 185-189, 2021 | 130 | 2021 |
| Lenalidomide-induced upregulation of CD80 on tumor cells correlates with T-cell activation, the rapid onset of a cytokine release syndrome and leukemic cell clearance in … G Aue, N Njuguna, X Tian, S Soto, T Hughes, B Vire, K Keyvanfar, ... haematologica 94 (9), 1266, 2009 | 122 | 2009 |
| Diuretic use, progressive heart failure, and death in patients in the DIG study M Domanski, X Tian, M Haigney, B Pitt Journal of cardiac failure 12 (5), 327-332, 2006 | 114 | 2006 |
| Iron, inflammation, and early death in adults with sickle cell disease EJ Van Beers, Y Yang, N Raghavachari, X Tian, DT Allen, JS Nichols, ... Circulation research 116 (2), 298-306, 2015 | 111 | 2015 |
| Prediction of outcome in patients with chronic lymphocytic leukemia treated with ibrutinib: development and validation of a four-factor prognostic model IE Ahn, X Tian, D Ipe, M Cheng, M Albitar, LC Tsao, L Zhang, W Ma, ... Journal of Clinical Oncology 39 (6), 576-585, 2021 | 107 | 2021 |
